Signaturefd LLC lifted its stake in shares of Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 40.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,122 shares of the company’s stock after buying an additional 322 shares during the period. Signaturefd LLC’s holdings in Molina Healthcare were worth $327,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Cibc World Markets Corp increased its stake in shares of Molina Healthcare by 14.0% in the fourth quarter. Cibc World Markets Corp now owns 9,112 shares of the company’s stock valued at $2,652,000 after buying an additional 1,117 shares during the period. Corient Private Wealth LLC increased its position in Molina Healthcare by 5.2% in the 4th quarter. Corient Private Wealth LLC now owns 5,437 shares of the company’s stock valued at $1,583,000 after acquiring an additional 271 shares during the period. Royce & Associates LP increased its position in Molina Healthcare by 15.5% in the 4th quarter. Royce & Associates LP now owns 35,654 shares of the company’s stock valued at $10,377,000 after acquiring an additional 4,787 shares during the period. Natixis Advisors LLC raised its stake in shares of Molina Healthcare by 6.7% during the fourth quarter. Natixis Advisors LLC now owns 29,928 shares of the company’s stock valued at $8,711,000 after acquiring an additional 1,881 shares during the last quarter. Finally, Aurora Investment Counsel lifted its holdings in shares of Molina Healthcare by 1.9% during the fourth quarter. Aurora Investment Counsel now owns 6,342 shares of the company’s stock worth $1,846,000 after purchasing an additional 117 shares during the period. 98.50% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
MOH has been the subject of a number of recent research reports. Barclays decreased their price objective on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a report on Friday, February 7th. Mizuho decreased their price target on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. StockNews.com lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, March 10th. Wells Fargo & Company raised shares of Molina Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Finally, UBS Group dropped their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $355.69.
Insiders Place Their Bets
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.10% of the company’s stock.
Molina Healthcare Stock Down 1.7 %
Molina Healthcare stock opened at $309.85 on Friday. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $17.20 billion, a PE ratio of 15.17, a PEG ratio of 1.06 and a beta of 0.56. The firm’s fifty day moving average is $299.99 and its 200 day moving average is $309.69. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $423.92.
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, sell-side analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Molina Healthcare Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
- Five stocks we like better than Molina Healthcare
- What Does a Stock Split Mean?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Business Services Stocks Investing
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What is an Earnings Surprise?
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.